[HTML][HTML] Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models

G González-Parra, MS Mahmud, C Kadelka - Infectious Disease Modelling, 2024 - Elsevier
As the world becomes ever more connected, the chance of pandemics increases as well.
The recent COVID-19 pandemic and the concurrent global mass vaccine roll-out provides …

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2· 57 million people in Scotland (EAVE II): a prospective cohort …

U Agrawal, SV Katikireddi, C McCowan… - The Lancet …, 2021 - thelancet.com
Summary Background The UK COVID-19 vaccination programme has prioritised vaccination
of those at the highest risk of COVID-19 mortality and hospitalisation. The programme was …

Immunogenicity of extended mRNA SARS-CoV-2 vaccine dosing intervals

B Grunau, DM Goldfarb, M Asamoah-Boaheng… - Jama, 2022 - jamanetwork.com
Methods| The COVID-19 Occupational Risks, Seroprevalence and Immunity among
Paramedics in Canada cohort study (approved by the University of British Columbia and …

Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo

MDT Hitchings, OT Ranzani, M Dorion… - Nature …, 2021 - nature.com
A two-dose regimen of the Oxford-AstraZeneca (ChAdOx1) Covid-19 vaccine with an inter-
dose interval of three months has been implemented in many countries with restricted …

[HTML][HTML] Shooting at a moving target—effectiveness and emerging challenges for sars-cov-2 vaccine development

F Guenl, A Mecate-Zambrano, S Rehlaender, S Hinse… - Vaccines, 2021 - mdpi.com
Since late 2019 the newly emerged pandemic SARS-CoV-2, the causative agent of COVID-
19, has hit the world with recurring waves of infections necessitating the global …

Humoral immune response in hematooncological patients and health care workers who received SARS-CoV-2 vaccinations

MJ Mair, JM Berger, AS Berghoff, AM Starzer… - JAMA …, 2022 - jamanetwork.com
Importance To our knowledge, little is known about antibody development after SARS-CoV-
2 vaccination in immunocompromised individuals, such as patients with cancer. Objective …

Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary

M Tré-Hardy, R Cupaiolo, A Wilmet… - Journal of Infection, 2021 - Elsevier
Objectives Scarce data are currently available on the kinetics of antibodies after vaccination
with mRNA vaccines as a whole and, with mRNA-1273, in particular. We report here an ad …

A higher antibody response is generated with a 6-to 7-week (vs standard) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine dosing interval

B Grunau, M Asamoah-Boaheng… - Clinical Infectious …, 2022 - academic.oup.com
The optimal dosing interval for severe acute respiratory syndrome coronavirus 2 vaccines
remains controversial. In this prospective study, we compared serology results of …

Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study

N Imai, T Rawson, ES Knock, R Sonabend… - The Lancet Public …, 2023 - thelancet.com
Background The UK was the first country to start national COVID-19 vaccination
programmes, initially administering doses 3 weeks apart. However, early evidence of high …

Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis

Y Liu, CAB Pearson, FG Sandmann… - The Lancet Regional …, 2022 - thelancet.com
Background In settings where the COVID-19 vaccine supply is constrained, extending the
intervals between the first and second doses of the COVID-19 vaccine may allow more …